112317 ⎘
Vectors comprising a special translation-regulating system controllable or inducible
PROBIOTIC LACTOBACILLUS STRAIN COMPOSITIONS AND APPLICATIONS THEREFOR INCLUDING FOR LEAKY GUT AND INFLAMMATION
#2COMPOSITIONS AND METHODS FOR VIROTHERAPY
#3Sense-and-Response of Proteins, Peptides, and Small Molecules Using Ligand-Induced Dimerization Activating RNA Editing (LIDAR)
#4SYSTEMS AND METHODS TO PRODUCE B CELLS THAT EXPRESS SELECTED ANTIBODIES AND GENE PRODUCTS
#5REGULATION OF GENE EXPRESSION BY APTAMER-MEDIATED MODULATION OF ALTERNATIVE SPLICING
#6TARGETED INTEGRATION OF NUCLEIC ACIDS
#7METHODS AND COMPOSITIONS TO PREVENT MICROBIAL INFECTION
#8SAFETY SWITCHES TO CONTROL IN VITRO AND IN VIVO PROLIFERATION OF CELL THERAPY PRODUCTS
#9MULTIPLEX ASSAY
#10REDUCTION OF IRON LEVELS BY IRON RESPONSIVE PROTEIN SEQUESTRATION WITH SHORT RNAS
#11CHIMERIC REPRESSORS AND METHODS OF USING THE SAME
#12APTAMERS AND SMALL MOLECULE LIGANDS
#13Target gene expression control system comprising dxCas9 and CRP derivative and preparation method therefor
#14BIOSENSORS FOR DETECTING AND/OR NEUTRALIZING BIOAVAILABLE URANIUM AND RELATED U-SENSITIVE GENETIC MOLECULAR COMPONENTS, GENE CASSETTES, VECTORS, GENETIC CIRCUITS, COMPOSITIONS, METHODS AND SYSTEMS
#15COMBINED TRANSPOSON-MEDIATED INTEGRATION AND TARGETED INTEGRATION OF NUCLEIC ACIDS INTO HOST CELLS
#16SYNTHETIC YEAST CELLS AND METHODS OF MAKING AND USING THE SAME
#17METHODS AND COMPOSITIONS USING AN ENGINEERED RELEASE FACTOR
#18UNIVERSAL RIBOSWITCH FOR INDUCIBLE GENE EXPRESSION
#19INDUCIBLE PROMOTERS
#20ANTI-IDIOTYPE COMPOSITIONS AND METHODS OF USE THEREOF
#21MICROORGANISMS PROGRAMMED TO PRODUCE IMMUNE MODULATORS AND ANTI-CANCER THERAPEUTICS IN TUMOR CELLS
#22PROTEIN CRYSTAL PRODUCTION METHOD AND CRYSTALLINE STRUCTURE ANALYSIS METHOD
#23PLASMID ADDICTION SYSTEM TO DRIVE DESIRED GENE EXPRESSION
#24VIRAL DELIVERY OF GAS VESICLE GENES
#25SYNTHETIC, PERSISTENT RNA CONSTRUCTS WITH ON/OFF MECHANISM FOR CONTROLLED EXPRESSION AND METHODS OF USE
#26CONTROLLED EXPRESSION OF VIRAL PROTEINS
#27METHODS AND COMPOSITIONS FOR TYPE 2 DIABETES THERAPY
#28PLATFORM FOR THE INDUCTION & MAINTENANCE OF GROUND STATE PLURIPOTENCY
#29REGULATION OF GENE EXPRESSION BY APTAMER-MEDIATED MODULATION OF ALTERNATIVE SPLICING
#30PLASMID ADDICTION SYSTEM TO DRIVE DESIRED GENE EXPRESSION
#31VIVO GUIDE RNA LIBRARIES AND METHODS OF MAKING THE SAME
#32DUX4 EXPRESSING CELLS AND USES THEREOF
#33CELLS FOR ENHANCED PRODUCTION OF ADENO-ASSOCIATED VIRUS
#34A GENETICALLY ENCODED PROTEIN SYNTHESIS INHIBITOR
#35REGULATABLE EXPRESSION USING ADENO-ASSOCIATED VIRUS (AAV)
#36NOVEL NUCLEIC ACID MODIFIERS
#37Live Attenuated Non-Transmissible Vaccines
#38Univariant Extrinsic Initiator Control System For Microbes And An In Vitro Assembly Of Large Recombinant DNA Molecules From Multiple Components
#39BACTERIAL EXPRESSION VECTOR FOR ENHANCED PROTEIN SECRETION
#40TARGETED INTEGRATION OF NUCLEIC ACIDS
#41Ligand Matched Transcription Control, Control Devices, and Solute Carriers
#42GENE THERAPY FOR OCULAR DISORDERS
#43Self-Selecting Sterile Male Arthropods
#44MULTIPLEX ASSAY
#45MODULATION OF MICROBIOTA COMPOSITIONS USING TARGETED NUCLEASES
#46Biosensors for detecting and/or neutralizing bioavailable uranium and related U-sensitive genetic molecular components, gene cassettes, vectors, genetic circuits, compositions, methods and systems
#47Method of detecting Polycomb Repressive Complex activity
#48Regulation of gene expression by aptamer-mediated modulation of alternative splicing
#49Gene therapy for ocular disorders
#50CONDITIONALLY IMMORTALIZED CELLS AND METHODS FOR THEIR PREPARATION
#51Microorganisms programmed to produce immune modulators and anti-cancer therapeutics in tumor cells
#52Univariant extrinsic initiator control system for microbes and an in vitro assembly of large recombinant DNA molecules from multiple components
#53Platform for the induction and maintenance of ground state pluripotency
#54Methods and compositions to prevent microbial infection
#55AMPLIFIED PRODUCTION OF MONOCLONAL ANTIBODIES
#56Plasmid addiction system to drive desired gene expression
#57REGULATABLE EXPRESSION USING ADENO-ASSOCIATED VIRUS (AAV)
#58Expression element, expression cassette, and vector containing the same
#59Compositions and methods for the modulation of root hair production and stress responses in plants
#60Synthetic yeast cells and methods of making and using the same
#61Ligand Matched Transcription Control, Control Devices, and Solute Carriers
#62Cell-free production of ribonucleic acid
#63D-amino acid-inducible gene expression system for and
#64Regulation of gene expression by aptamer-mediated modulation of alternative splicing
#65Sequence arrangements and sequences for neoepitope presentation
#66Methods and compositions for perturbing gene expression in hematopoietic stem cell lineages in vivo
#67Blue light-inducible system for gene expression
#68DNA recombinase circuits for logical control of gene expression
#69Reduction of Tobacco-Specific Nitrosamines Using Genetic Modification to Elevate Production of Native Antioxidants in Tobacco
#70BIOCONTROL
#71Inducible mutagenesis of target genes
#72DESIGNER PH SENSOR AS UNIVERSAL TRANSGENE CONTROLLER
#73Inducible mutagenesis of target genes
#74Univariant Extrinsic Initiator Control System for Microbes and an In Vitro Assembly of Large Recombinant DNA Molecules From Multiple Components
#75Biocontrol
#76Synthetic transcriptional control elements and methods of generating and using such elements
#77Compositions, methods and uses for expression of enterobacterium-associated peptides
#78GLYCINE RIBOSWITCHES, METHODS FOR THEIR USE, AND COMPOSITIONS FOR USE WITH GLYCINE RIBOSWITCHES
#79Methods concerning PPAR delta and antagonists thereof
#80Unconventional antigen translated by a novel internal ribosome entry site elicits antitumor humoral immune reactions
#81B cells modified to reversibly induce accelerated mutagenesis of target genes
#82Conditional-stop dimerizable caspase transgenic animals
#83Glycine riboswitches, methods for their use, and compositions for use with glycine riboswitches Cross-Reference to Related Applications
#84Tumor mouse models using lentiviral vectors
#85Reduction of tobacco-specific nitrosamines using genetic modification to elevate production of native antioxidants in tobacco